HLA-G immune checkpoint in Oncology and Transplantation
Posted by
aline
on 1 July 2021
Human keratinocytes inhibit CD4+ T-cell proliferation through TGFB1 secretion and surface expression of HLA-G1 and PD-L1 immune checkpoints
Mestrallet G., Auvré F., Schenowitz C., Carosella ED., LeMaoult J., Martin MT., Rouas-Freiss N., Fortunel [...]
Read morePosted by
aline
on 1 July 2021
HLA-G/LILRBs: A Cancer Immunotherapy Challenge
Carosella ED, Gregori S, Tronik-Le Roux D. Nature : rends Cancer. 2021 May;7(5):389-392.. Doi : [...]
Read morePosted by
fsena
on 30 July 2020
Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets
Tronik-Le Roux D, Sautreuil M, Bentriou M, Vérine J, Palma MB, Daouya M, Bouhidel F, Lemler S, LeMaoult J, [...]
Read morePosted by
fsena
on 3 July 2020
The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma
García M, Palma MB, Verine J, Miriuka S, Inda AM, Errecalde AL, Desgrandchamps F, Carosella ED, Tronik-Le [...]
Read morePosted by
fsena
on 4 February 2020
Are the immune properties of mesenchymal stem cells from Wharton Jelly maintained during chondrogenic differentiation?
Voisin C., Cauchois G., Reppel L., Laroye C., Louarn L., Schenowitz C., Sonon P., Poras I., Wang V., [...]
Read morePosted by
fsena
on 30 October 2019
CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G
Dumont C, Jacquier A, Verine J, Noel F, Goujon A, Wu CL, Hung TM, Desgrandchamps F, Culine S, Carosella ED, [...]
Read morePosted by
fsena
on 4 September 2018
Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8+ T cells
Desgrandchamps F, LeMaoult J, Goujon A, Riviere A, Rivero-Juarez A, Djouadou M, de Gouvello A, Dumont C, Wu [...]
Read morePosted by
fsena
on 4 April 2018
The genetic diversity within the 1.4 kb HLA-G 5′ upstream regulatory region moderately impacts on cellular microenvironment responses
Dias FC, Bertol BC, Poras I, Souto BM, Mendes-Junior CT, Castelli EC, Gineau L, Sabbagh A, Rouas-Freiss N, [...]
Read morePosted by
fsena
on 30 November 2017
Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients
Tronik-Le Roux D, Renard J, Vérine J, Renault V, Tubacher E, LeMaoult J, Rouas-Freiss N, Deleuze JF, [...]
Read morePosted by
fsena
on 5 July 2017
Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4
Rouas-Freiss N, LeMaoult J, Verine J, Tronik-Le Roux D, Culine S, Hennequin C, Desgrandchamps F, Carosella [...]
Read more